Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.

Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.

Fish oil has been used effectively in the treatment of cardiovascular disease via triglyceride reduction and inflammation modulation. This study aimed to assess the effects of fish oil on patients with nonalcoholic fatty liver disease (NAFLD) associated with hyperlipidemia. Eighty participants with...

Full description

Bibliographic Details
Main Authors: Yu Qin, Yong Zhou, Shi-Hui Chen, Xiao-Lan Zhao, Li Ran, Xiang-Long Zeng, Ying Wu, Jun-Li Chen, Chao Kang, Fu-Rong Shu, Qian-Yong Zhang, Man-Tian Mi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4520650?pdf=render

Internet

http://europepmc.org/articles/PMC4520650?pdf=render

Similar Items